Axsome Therapeutics, Inc. (AXSM) on GreekSoup https://greeksoup.ai/stocks/us/axsm/ Every dated entry in the public record on Axsome Therapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Axsome Therapeutics, Inc.: short interest 3,111,573 shares at the 15 October 2026 settlement, 3.34 days to coverhttps://greeksoup.ai/stocks/us/axsm/short-interest/us:AXSM:short-interest:2026-10-15:807fccd00aThu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Axsome Therapeutics, Inc.: short interest 3,306,417 shares at the 30 September 2026 settlement, 4.36 days to coverhttps://greeksoup.ai/stocks/us/axsm/short-interest/us:AXSM:short-interest:2026-09-30:5ae8bda12fWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Axsome Therapeutics, Inc.: short interest 3,139,787 shares at the 15 September 2026 settlement, 5.19 days to coverhttps://greeksoup.ai/stocks/us/axsm/short-interest/us:AXSM:short-interest:2026-09-15:02a532ee80Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Axsome Therapeutics, Inc.: Form 144, Mark Jacobson plans to sell 10,000 shares worth $2.1 million around 3 September 2026https://greeksoup.ai/stocks/us/axsm/planned-sales/us:AXSM:planned-sale:2026-09-03:fcf93cfb89Thu, 03 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Axsome Therapeutics, Inc.: Jacobson Mark L. (Chief Operating Officer) sold 10,000 shares (under a trading plan set in advance) at $208.65 on 3 September 2026, $2.1 millionhttps://greeksoup.ai/stocks/us/axsm/insiders/us:AXSM:insider:2026-09-03:43dd8abf7fThu, 03 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Axsome Therapeutics, Inc.: short interest 3,080,218 shares at the 31 August 2026 settlement, 5.83 days to coverhttps://greeksoup.ai/stocks/us/axsm/short-interest/us:AXSM:short-interest:2026-08-31:a9c6e6667bMon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Axsome Therapeutics, Inc.: short interest 3,205,664 shares at the 14 August 2026 settlement, 3.98 days to coverhttps://greeksoup.ai/stocks/us/axsm/short-interest/us:AXSM:short-interest:2026-08-14:2888ccffc7Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Axsome Therapeutics, Inc. Q2 FY2026 results: revenue $218 million, net income -$51 millionhttps://greeksoup.ai/stocks/us/axsm/results/fy2026-q2/us:AXSM:result:2026-08-10:8f97f0e08aMon, 10 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Axsome Therapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/axsm/filings/us:AXSM:filing:2026-08-10:627adb15daMon, 10 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Axsome Therapeutics, Inc. filed 8-K: results of operations, other eventshttps://greeksoup.ai/stocks/us/axsm/filings/us:AXSM:filing:2026-08-10:669db4089fMon, 10 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Axsome Therapeutics, Inc.: Tabuteau Herriot (Chief Executive Officer) sold 4,660 shares (under a trading plan set in advance) at $213.95 on 6 August 2026, $997,007https://greeksoup.ai/stocks/us/axsm/insiders/us:AXSM:insider:2026-08-07:98b5f243d4Fri, 07 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Axsome Therapeutics, Inc.: Tabuteau Herriot (Chief Executive Officer) sold 45,004 shares (under a trading plan set in advance) at $212.01 on 5 August 2026, $9.5 millionhttps://greeksoup.ai/stocks/us/axsm/insiders/us:AXSM:insider:2026-08-07:5e49129145Fri, 07 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Axsome Therapeutics, Inc.: Form 144, Herriot Tabuteau plans to sell 4,660 shares worth $979,206 around 6 August 2026https://greeksoup.ai/stocks/us/axsm/planned-sales/us:AXSM:planned-sale:2026-08-06:4622ba1406Thu, 06 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Axsome Therapeutics, Inc.: Form 144, Herriot Tabuteau plans to sell 45,004 shares worth $9.6 million around 5 August 2026https://greeksoup.ai/stocks/us/axsm/planned-sales/us:AXSM:planned-sale:2026-08-05:456679fd2aWed, 05 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Axsome Therapeutics, Inc.: short interest 3,407,383 shares at the 31 July 2026 settlement, 5.11 days to coverhttps://greeksoup.ai/stocks/us/axsm/short-interest/us:AXSM:short-interest:2026-07-31:e1b4c14ab9Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>